000 | 01854 a2200469 4500 | ||
---|---|---|---|
005 | 20250513235737.0 | ||
264 | 0 | _c20011025 | |
008 | 200110s 0 0 eng d | ||
022 | _a1523-6838 | ||
024 | 7 |
_a10.1016/s0272-6386(05)80012-5 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMaccarrone, M | |
245 | 0 | 0 |
_aVitamin E suppresses 5-lipoxygenase-mediated oxidative stress in peripheral blood mononuclear cells of hemodialysis patients regardless of administration route. _h[electronic resource] |
260 |
_bAmerican journal of kidney diseases : the official journal of the National Kidney Foundation _cMay 2001 |
||
300 |
_a964-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 |
_aArachidonate 5-Lipoxygenase _xgenetics |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aGene Expression Regulation, Enzymologic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInjections, Intramuscular |
650 | 0 | 4 |
_aKidney Failure, Chronic _xetiology |
650 | 0 | 4 |
_aLeukocytes, Mononuclear _xdrug effects |
650 | 0 | 4 |
_aLeukotriene B4 _xmetabolism |
650 | 0 | 4 |
_aMembrane Lipids _xanalysis |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
650 | 0 | 4 | _aRenal Dialysis |
650 | 0 | 4 | _aUp-Regulation |
650 | 0 | 4 |
_aVitamin E _xadministration & dosage |
700 | 1 | _aMeloni, C | |
700 | 1 | _aManca-di-Villahermosa, S | |
700 | 1 | _aCococcetta, N | |
700 | 1 | _aCasciani, C U | |
700 | 1 | _aFinazzi-Agrò, A | |
700 | 1 | _aTaccone-Gallucci, M | |
773 | 0 |
_tAmerican journal of kidney diseases : the official journal of the National Kidney Foundation _gvol. 37 _gno. 5 _gp. 964-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0272-6386(05)80012-5 _zAvailable from publisher's website |
999 |
_c11259649 _d11259649 |